Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

metastatic colorectal cancer

  • Open Access
    Bone Toxicity Case Report Combining Encorafenib, Cetuximab and WNT974 in a Phase I Trial
    MARK T.J. VAN BUSSEL, NATHALIE BRAVENBOER, HUIB VAN ESSEN, PETUR SNAEBJORNSSON, NATASHA M. APPELMAN-DIJKSTRA, JAN HM SCHELLENS and FRANS L. OPDAM
    Anticancer Research July 2025, 45 (7) 3137-3147; DOI: https://doi.org/10.21873/anticanres.17677
  • You have access
    Adjusting Treatment Strategies Using Circulating Tumor Cells: Preliminary Results on Metastatic Colorectal Cancer
    JOACHIM DREVS, MANDEEP SINGH MALHOTRA, HUSEYIN SAHINBAS, AGGELOS ILIOPOULOS, GEORGE BEIS, PANAGIOTIS APOSTOLOU and IOANNIS PAPASOTIRIOU
    Anticancer Research February 2025, 45 (2) 491-502; DOI: https://doi.org/10.21873/anticanres.17438
  • You have access
    Development of a Prognostic Model for Stage IV Colorectal Cancer Using Metastatic Patterns
    HIDETAKA KAWAMURA, TAKAHIRO IMAIZUMI, TEPPEI MIYAKAWA, EIICHI NAKAO, MASANORI KATAGATA, YUKITOSHI TODATE, YOSHINAO TAKANO, KOJI KONO and MICHITAKA HONDA
    Anticancer Research January 2025, 45 (1) 341-350; DOI: https://doi.org/10.21873/anticanres.17422
  • You have access
    Alternating Oxaliplatin and Irinotecan Chemotherapy Combined With Capecitabine and Bevacizumab for Microsatellite-stable Stage IV Metastatic Colon Cancer With a BRAF V600E Mutation: Two Case Reports Indicating Survival Improvement over Standard Therapy
    YAOYI ZHANG, XIAOHUI LI, SHENG LI, ZHIJIAN YANG, ROBERT M. HOFFMAN and CHEN YU
    Anticancer Research January 2025, 45 (1) 399-404; DOI: https://doi.org/10.21873/anticanres.17428
  • You have access
    Comparative Effectiveness of Adjuvant Therapy on Survival in Patients With Metastatic Colorectal Cancer
    CHIH-CHIEN WU, CHIEN-CHOU SU, YU-HSUN CHEN, CHAO-WEN HSU, YU-CHING CHANG and YI-CHIA SU
    Anticancer Research April 2024, 44 (4) 1619-1628; DOI: https://doi.org/10.21873/anticanres.16960
  • You have access
    Comparative Effectiveness of Cetuximab Versus Panitumumab in Patients With Metastatic Colorectal Cancer: A Nationwide Database Study
    CHIH-CHIEN WU, CHIEN-CHOU SU, YU-HSUN CHEN, CHAO-WEN HSU, MENG-CHE HSIEH, YU-CHING CHANG, YUNG-CHANG WANG and YI-CHIA SU
    Anticancer Research November 2023, 43 (11) 5127-5138; DOI: https://doi.org/10.21873/anticanres.16713
  • You have access
    Anti-VEGF and Anti-EGFR Antibody Therapy on T-Cell Infiltration and TCR Variation in Metastatic Colorectal Cancer
    MING XU, RYOUICHI TSUNEDOMI, KAZUMA KIYOTANI, SHINOBU TOMOCHIKA, KEI FURUYA, MASAO NAKAJIMA, HIROTO MATSUI, YUKIO TOKUMITSU, YOSHITARO SHINDO, SHIN YOSHIDA, MICHIHISA IIDA, NOBUAKI SUZUKI, SHIGERU TAKEDA, TATSUYA IOKA, SHOICHI HAZAMA and HIROAKI NAGANO
    Anticancer Research February 2023, 43 (2) 613-620; DOI: https://doi.org/10.21873/anticanres.16197
  • Open Access
    Serum CCL7 Is a Novel Prognostic Biomarker of Metastatic Colorectal Cancer
    HIKARI CHIDIMATSU, RYOUICHI TSUNEDOMI, YUKI NAKAGAMI, MING XU, MASAO NAKAJIMA, CHIYO NAKASHIMA-NAKASUGA, SHINOBU TOMOCHIKA, SHIN YOSHIDA, NOBUAKI SUZUKI, YUSAKU WATANABE, HIROTO MATSUI, YOSHITARO SHINDO, YUKIO TOKUMITSU, MICHIHISA IIDA, SHIGERU TAKEDA, TATSUYA IOKA, TOMIO UENO, TSUYOSHI TANABE, YOSHINOBU HOSHII, SHOICHI HAZAMA and HIROAKI NAGANO
    Anticancer Research January 2023, 43 (1) 105-114; DOI: https://doi.org/10.21873/anticanres.16139
  • You have access
    A Phase II Study of Dose-reductive XELOX Plus Bevacizumab in Elderly or Vulnerable Patients With Metastatic Colorectal Cancer (MCSGO-1202)
    AYA KATO, NORIKATSU MIYOSHI, TORU OHTSURU, DAISUKE SAKAI, JUNICHI HASEGAWA, KEN NAKATA, MITSUNOBU IMASATO, TAKESHI KATO, MASAKAZU IKENAGA, TOSHIHIRO KUDO, MITSUYOSHI TEI, YOSHINORI KAGAWA, MAMORU UEMURA, HIDEKAZU TAKAHASHI, TAROH SATOH, MASAKI MORI, TSUNEKAZU MIZUSHIMA, HIROFUMI YAMAMOTO, KOHEI MURATA, YUICHIRO DOKI and HIDETOSHI EGUCHI
    Anticancer Research April 2022, 42 (4) 1859-1865; DOI: https://doi.org/10.21873/anticanres.15662
  • You have access
    The Efficacy and Safety of Trifluridine/Tipiracil Treatment for Elderly Patients With Metastatic Colorectal Cancer in a Real-world Setting
    MASATSUNE SHIBUTANI, WANG EN, YUKI OKAZAKI, SHINICHIRO KASHIWAGI, TATSUNARI FUKUOKA, YASUHITO ISEKI, KOSEI HIRAKAWA and MASAICHI OHIRA
    Anticancer Research December 2021, 41 (12) 6211-6216; DOI: https://doi.org/10.21873/anticanres.15440

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire